Adricin 10mg Injection
Marketer
Adley Formulations
Salt Composition
Epirubicin (10mg)
Overview Adricin 10mg Injection
Adricin 10mg Injection treats various hematological malignancies and cancers affecting the breast, stomach, lungs, ovaries, and soft tissues. It also aids in preventing bladder cancer relapse post-surgery. Administered intravenously by a healthcare professional, it's used alone or in combination chemotherapy regimens, with dosage determined by your oncologist based on your condition and adjusted as needed. Strict adherence to your prescribed regimen is vital; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be immediately apparent, requiring weeks or months; discontinue only under medical supervision. Contraceptive measures are strongly recommended for both partners as Adricin reduces contraceptive pill efficacy. Common side effects include nausea, thrombocytopenia, alopecia, amenorrhea, pyrexia, and dermatological reactions. Reduced blood cell counts increase infection risk, potentially life-threatening; regular blood tests monitor blood cell levels and vital organ function (kidney, liver, heart). Prior to treatment, disclose any liver or heart conditions, and provide a complete medication list to your doctor, as drug interactions can compromise Adricin's efficacy. Inform your physician of pregnancy or breastfeeding.
Uses of Adricin 10mg Injection
Malignancy
Major Benefits of Adricin 10mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Adricin 10mg Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Adricin 10mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Adricin 10mg Injection works:
Adricin 10mg Injection is a breast cancer treatment that inhibits topoisomerase II, an enzyme crucial for breast cancer cell DNA replication. This inhibition, coupled with the generation of cytotoxic free radicals, damages the cancer cells' DNA, hindering their proliferation and ultimately leading to their demise.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Adricin 10mg Injection is dangerous.
PregnancyCONSULT YOUR DOCTOR
Administering Adricin 10mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional circumstances involving a life-threatening condition, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administration of Adricin 10mg Injection is contraindicated while breastfeeding due to potential infant toxicity.
DrivingUNSAFE
Adricin 10mg Injection can produce adverse reactions that might hinder driving capabilities. Nausea and vomiting, potential side effects of Adricin 10mg Injection, may temporarily compromise the ability to operate a vehicle.
KidneySAFE IF PRESCRIBED
Adricin 10mg Injection appears to be well-tolerated in individuals with impaired renal function. Current evidence indicates dose modification for Adricin 10mg Injection may be unnecessary in this population. Physician consultation is recommended. Reduced dosages might be appropriate for patients exhibiting serum creatinine levels exceeding 5 mg/dL.
LiverCAUTION
Adricin 10mg Injection requires careful administration in individuals with hepatic impairment. Dosage modification for Adricin 10mg Injection may be necessary. Physician consultation is advised. Adricin 10mg Injection is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Adricin 10mg Injection :
NA
Facts to Know About Adricin 10mg Injection
| Label | Value |
|---|---|
| Pharmaceutical Classification | Anthracycline-based drug |
| Addiction potential | None. |
| Medication Classification | Cancer therapies |
| Mechanism of Action | Plant-derived anti-cancer compounds |
3,018 People bought this recently